Document Detail


Subvalvular alterations promote increased mitral valve regurgitation in progressive dilated cardiomyopathy.
MedLine Citation:
PMID:  15948084     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Alterations in transmitral pressure, valve structure, subvalvular geometry, and abnormal myocardial function have all been implicated in the pathophysiology of functional/progressive mitral valve regurgitation (MR). In this study, we hypothesized that a relatively small structural lesion to the mitral valve apparatus predisposes to severe MR in the setting of progressive left ventricular dilation. While examining this hypothesis, an additional purpose of this study was to determine the extent of papillary muscle (PM) distortion and mitral annular dilation with increasing MR resulting from progressive dilated cardiomyopathy. METHODS AND RESULTS: Mild MR was produced via a limited, fixed structural lesion to the mitral valve apparatus of 8 dogs (20 to 22 kg). Incremental tachypacing induced left ventricular dilation over an 8-month period. The pacer was deactivated and the dogs followed for an additional 6 weeks. Echocardiographic measurements demonstrated significant cardiac remodeling (left ventricular end diastolic diameter) and MR progression with a 54% increase in left ventricular end diastolic diameter and a 44% increase in MR jet area (P < .05). Tachypacing induced decreases in left ventricular ejection fraction recovered nearly to baseline levels by 6 weeks after pacing cessation. Nevertheless, left ventricular dilation persisted and MR remained severe after pacing cessation. There was a significant increase in the short axis PM segment length and PM angular separation from baseline (6.28 +/- 0.83 versus 4.02 +/- 0.56 cm and 99.7 +/- 2.6 versus 90.1 +/- 3.2 deg, respectively, P < .05) with no change in mitral annulus circumference (8.71 +/- 0.70 versus 8.15 +/- 0.35 cm, P = NS). CONCLUSION: Progressive MR severity in nonischemic dilated cardiomyopathy resulted from changes in left ventricular shape and altered papillary muscle geometries and does not require mitral annulus dilation or a reduced left ventricular ejection fraction.
Authors:
Joseph C McGinley; Remus M Berretta; George D Bratinov; Sunil Dhar; John P Gaughan; Kenneth B Margulies
Related Documents :
1452934 - Left ventricular shape is the primary determinant of functional mitral regurgitation in...
18558474 - The angle of the components of the common atrioventricular valve predicts the outcome o...
12583854 - Trends in the surgical management of ischemic mitral regurgitation.
6459024 - Quantitation of left ventricular regurgitant fraction by first pass radionuclide angioc...
9785054 - Clinical trials of reducing low-density lipoprotein concentrations.
11297214 - In-vitro measurements of the regurgitation of mechanical mitral heart valve prostheses ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiac failure     Volume:  11     ISSN:  1071-9164     ISO Abbreviation:  J. Card. Fail.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-10     Completed Date:  2005-11-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9442138     Medline TA:  J Card Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  343-50     Citation Subset:  IM    
Affiliation:
The Cardiovasc Res Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cardiomyopathy, Dilated / etiology*,  physiopathology,  ultrasonography
Disease Models, Animal
Disease Progression
Dogs
Echocardiography, Doppler
Echocardiography, Transesophageal
Mitral Valve Insufficiency / complications*,  physiopathology,  ultrasonography
Papillary Muscles / physiopathology,  ultrasonography*
Severity of Illness Index
Stroke Volume / physiology
Ventricular Remodeling / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.
Next Document:  Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support.